Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 181-190 of 411 for multiple

Edit search filters
  1. Instrument for Patient Capacity Assessment (ICAN) in Patients with Multiple Chronic Conditions

    Rochester, MN

  2. Single And Multiple Dose Escalation Of PHIN-214 In Child-Pugh A And B Liver Cirrhotics

    Rochester, MN

  3. A Study Of DFRF4539A In Patients With Relapsed Or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  4. Efficacy And Safety Study Of Frexalimab (SAR441344) In Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis

    Jacksonville, FL

  5. Ixazomib Citrate, Pomalidomide, Dexamethasone, And Stem Cell Transplantation In Treating Patients With Relapsed Or Refractory Multiple Myeloma

    Rochester, MN

  6. A Dose Finding Study Followed By A Safety And Efficacy Study For Patients With Multiple Myeloma Or Lymphoma

    Rochester, MN

  7. Bortezomib, Melphalan, And Total-Body Irradiation Before Stem Cell Transplant In Treating Patients With Multiple Myeloma

    Rochester, MN

  8. Phase 1 Study To Evaluate The Safety Of ATA188 In Subjects With Progressive And Relapsing-Remitting Multiple Sclerosis

    Scottsdale/Phoenix, AZ

  9. A Multi-centered, Double-blind, Randomized, Placebo-controlled Study Of TEV-56286 For The Treatment Of Multiple System Atrophy

    Rochester, MN

  10. Dinaciclib, Bortezomib, And Dexamethasone In Treating Patients With Relapsed Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer